General Biologicals Corporation (TPEX:4117)

General Biologicals Revenue

General Biologicals had revenue of 105.01M TWD in the half year ending December 31, 2025, a decrease of -19.92%. This brings the company's revenue in the last twelve months to 260.23M, up 3.52% year-over-year. In the year 2025, General Biologicals had annual revenue of 215.74M, down -14.36%.

• Revenue (ttm): 260.23M
• Revenue Growth: +3.52%
• P/S Ratio: 2.80
• Revenue / Employee: 3.21M
• Employees: 81
• Market Cap: 729.50M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	215.74M	-36.19M	-14.36%
Dec 31, 2024	251.93M	-12.90M	-4.87%
Dec 31, 2023	264.83M	-105.63M	-28.51%
Dec 31, 2022	370.46M	-181.20M	-32.85%
Dec 31, 2021	551.66M	75.79M	15.93%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 18, 2026

Data Sources Report a data error